GSK Pledges $30 Billion of US Investment as Trump Visits UK (1)

British drugmaker GSK Plc pledged to invest $30 billion in the US over the next five years, making the announcement as President Donald Trump arrived in the UK for a highly anticipated state visit.

The move follows similar announcements by other pharmaceutical companies, after Trump threatened tariffs on imported drugs and complained about high prices paid by Americans. The US accounts for about 50% of GSK’s revenue.

GSK shares were little changed in early trading in London. They have risen 8.7% this year through Tuesday’s close.

Chief Executive Officer Emma Walmsley said earlier this year GSK planned to invest tens ...